Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365.

Journal of medicinal chemistry·2026
Same author

Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud Irishman.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Single-cell epigenetic landscape, microenvironment interactions, and gene regulatory modules of non-functioning pituitary adenomas.

Cell systems·2026
Same author

Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud Irishman.

Proceedings of the National Academy of Sciences of the United States of America·2026

関連する実験動画

Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

ホルモン療法:生理学的複雑さは,治療の単純さを偽っている.

Judith L Turgeon1, Donald P McDonnell, Kathryn A Martin

  • 1Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California-Davis, Davis, CA 95616, USA. jlturgeon@ucdavis.edu

Science (New York, N.Y.)
|May 29, 2004
PubMed
まとめ

閉経後のホルモン療法 (HT) の結果は議論されている. 分子レベルでエストロゲンとプロゲスチンの作用を理解することは,HTプロトコルと薬物開発の精製の鍵です.

科学分野:

  • 内分泌学と分子生物学について
  • 生殖器保健は,生殖器の健康についてです.

背景:

  • 女性の健康イニシアティブの研究は,閉経後のホルモン療法 (HT) のリスクと利益を明らかにすることを目的とした.
  • 研究結果は,医療従事者や一般市民の間で大きな議論と混乱を引き起こした.
  • 閉経は卵巣ホルモン (エストロゲンとプロゲステロン) の低下を伴い,様々な身体組織に影響を及ぼします.

研究 の 目的:

  • エストロゲンとプロゲスティンの組織特異的作用をレビューする.
  • ステロイドホルモン内分泌学知識の臨床研究への統合を評価する.
  • 現在のホルモン療法プロトコルと医薬品の進歩への影響を検討する.

主な方法:

  • エストロゲンとプロゲステンの作用に関する現在の科学文献のレビュー.
  • 分子内分泌学の洞察が臨床試験の設計にどのように影響するかを分析する.
  • 現代のホルモン療法戦略に対する影響の評価.

主要な成果:

  • 分子生物学における進歩は,ステロイドホルモンの異なる作用を定義しています.
  • これらの分子メカニズムを理解することは,臨床研究結果の解釈に極めて重要です.
  • 内分泌学に関する既存の知識は,臨床研究に変化的に組み込まれています.

さらに関連する動画

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

関連する実験動画

Last Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

結論:

  • エストロゲンとプロゲステンのより深い分子理解は,HT論争の解決に不可欠です.
  • 内分泌学研究の統合を改善することで,ホルモン療法プロトコルを最適化することができます.
  • この知識は,女性の健康における将来の医薬品開発に不可欠です.